Gel-forming block copolymers were prepared comprising i) a central hydrophilic block consisting essentially of a divalent poly(ethylene oxide) chain and ii) two peripheral monocarbonate or polycarbonate hydrophobic blocks linked to the central block by linking groups bearing one or more hydrogen bond forming *—N(H)—* groups. The hydrophobic blocks comprise one or more vitamin-bearing subunits. The gel-forming block copolymers can be used to prepare various biodegradable and/or biocompatible hydrogel and organogel drug compositions, in particular antimicrobial and/or anti-tumor drug compositions. The hydrogel compositions have utility in depot injections for drug delivery. The hydrogen bonding *—N(H)—* group(s) provide longer in vivo lifetime of the hydrogel before degradation and a more prolonged and controlled release rate of a hydrophobic drug compared to similar hydrogels prepared from poly(ethylene glycol).
制备了包含以下组成部分的凝胶形成嵌段共聚物:i)主要由二价聚
乙二醇链组成的中心亲
水性块和ii)通过带有一个或多个
氢键形成*—N(H)—*基团连接到中心块的两个外周单
碳酸酯或多
碳酸酯疏
水性块。疏
水性块包含一个或多个含
维生素的亚单位。这些凝胶形成嵌段共聚物可用于制备各种可
生物降解和/或
生物相容的
水凝胶和有机凝胶药物组合物,特别是抗微
生物和/或
抗肿瘤药物组合物。
水凝胶组合物在药物输送的库存注射中具有实用性。与由聚
乙二醇制备的类似
水凝胶相比,
氢键*—N(H)—*基团提供了凝胶在体内降解之前更长的生命周期,以及与
水凝胶相比更延长和控制释放速率的疏
水性药物。